JOSHA
Donate
Browse Area

Medicine

Dedicated to biology, health sciences, and medical research, this category highlights advancements in understanding life processes and improving healthcare

137 Publications

Current trends in Community-acquired methicillin-resistant Staphylococcus aureus in Argentina
Medicine
| DOI: 10.17160/josha.2.3.33

Current trends in Community-acquired methicillin-resistant Staphylococcus aureus in Argentina

M

Marta Mollerach

University of Buenos Aires, Department of Microbiology, Immunology and Biotechnology

Community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) infections have become a major concern worldwide. Different from hospital-acquired MRSA, CA-MRSA usually is staphylococcal cassette chromosome (SCCmec) type IV, carries genes for Panton-Valentine leukocidin…

1,873
4,239
PDF
Cancer: A Story of Stem Cells and Evolution
Medicine
| DOI: 10.17160/josha.2.2.20

Cancer: A Story of Stem Cells and Evolution

R

Roland Mertelsmann

Albert-Ludwigs Universität

Cancer is an acquired genetic disease of clonal origin. Carcinogenesis and its subsequent development follow the principles of evolution, starting with a single cell with stem cell properties and a…

2,581
5,426
PDF
Interferon-stimulated gene expression in chronic hepatitis C virus genotype 1 infected patients treated with the NS3/4A protease inhibitor faldaprevir in combination with pegylated interferon alpha-2a/ribavirin
Medicine
| DOI: 10.17160/josha.2.1.15

Interferon-stimulated gene expression in chronic hepatitis C virus genotype 1 infected patients treated with the NS3/4A protease inhibitor faldaprevir in combination with pegylated interferon alpha-2a/ribavirin

Y

Yakov Datsenko

The objective of this study was to investigate the expression of selected interferon-stimulated genes (ISGs) in PBMC (peripheral blood mononuclear cell) prior and during the treatment with NS3/NS4A protease inhibitor…

1,716
4,073
PDF
Behandlung der Immunthrombozytopenie mit Rituximab:Ergebnisse einer klinischen Studie konsekutiver Patienten von September 2000 bis März 2010
Medicine
| DOI: 10.17160/josha.2.1.13

Behandlung der Immunthrombozytopenie mit Rituximab:Ergebnisse einer klinischen Studie konsekutiver Patienten von September 2000 bis März 2010

R

Rieke Marks

Die Immunthrombozytopenie (ITP) ist eine Autoimmunkrankheit, die mit der Zerstörung körpereigener Thrombozyten einhergeht. Ein immunologischer Toleranzverlust gegenüber körpereigenen Antigenen auf der Zelloberfläche der Thrombozyten führt zu einer verkürzten Lebenszeit der…

2,413
5,112
PDF